Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Edler

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Alternatives to Laboratory Animals : ATLA|July 30, 2008
Points of reference in the validation process: the report and recommendations of ECVAM Workshop 66Sebastian Hoffmann, Lutz Edler, Ian Gardner, et al.
Blood|December 12, 2007
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosisSven Baumann, Stefanie C Fas, Marco Giaisi, et al.
Environmental and Molecular Mutagenesis|September 5, 2002
New measure of DNA repair in the single-cell gel electrophoresis (comet) assayByung-Soo Kim, Jin Joo Park, Lutz Edler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)Eckart Laack, Antje Scheffler, Iris Burkholder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2007
Lectin histochemistry of metastatic adenocarcinomas of the lungIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
BMC Cancer|November 11, 2010
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trialStephanie E Combs, Lutz Edler, Iris Burkholder, et al.
BMC Cancer|October 8, 2010
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trialStephanie E Combs, Iris Burkholder, Lutz Edler, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Michael Görn, Manuela Anige, Iris Burkholder, et al.
Anticancer Research|April 1, 2009
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastasesIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2010
Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect modelIngmar Schlampp, Christian P Karger, Oliver Jäkel, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Alternatives to Laboratory Animals : ATLA|July 30, 2008
Points of reference in the validation process: the report and recommendations of ECVAM Workshop 66Sebastian Hoffmann, Lutz Edler, Ian Gardner, et al.
Blood|December 12, 2007
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosisSven Baumann, Stefanie C Fas, Marco Giaisi, et al.
Environmental and Molecular Mutagenesis|September 5, 2002
New measure of DNA repair in the single-cell gel electrophoresis (comet) assayByung-Soo Kim, Jin Joo Park, Lutz Edler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)Eckart Laack, Antje Scheffler, Iris Burkholder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2007
Lectin histochemistry of metastatic adenocarcinomas of the lungIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
BMC Cancer|November 11, 2010
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trialStephanie E Combs, Lutz Edler, Iris Burkholder, et al.
BMC Cancer|October 8, 2010
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trialStephanie E Combs, Iris Burkholder, Lutz Edler, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Michael Görn, Manuela Anige, Iris Burkholder, et al.
Anticancer Research|April 1, 2009
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastasesIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2010
Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect modelIngmar Schlampp, Christian P Karger, Oliver Jäkel, et al.
Pageof 13